Streetbeat News

Stock Prices

ANF

NKE

Nike shares are declining, possibly in sympathy with Foot Locker and Abercrombie & Fitch, which reported earnings. Foot Locker reported a smaller-than-expected loss and Abercrombie exceeded sales and EPS estimates. The apparel sector, including Under Armour, is under pressure.

Portfolio Pulse from Dylan Berman

August 28, 2024 | 5:41 pm

CHPT

PBW

SIMS

ChargePoint Holdings, Inc. (NYSE:CHPT) is facing a challenging Q3 outlook due to industry headwinds, according to J.P. Morgan analyst Bill Peterson. The analyst expects Q3 guidance to fall below consensus, although the second half of the year may improve. Investor sentiment is cautious, but an Overweight rating is maintained. CHPT shares are down 3.54%.

Portfolio Pulse from Lekha Gupta

August 28, 2024 | 5:38 pm

SERV

Serve Robotics Inc. (NASDAQ:SERV) has closed a $20 million private placement and warrant exercise, leading to a positive impact on its stock price.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 5:36 pm

BLDR

HWM

LYFT

NVT

RUN

UAL

VRT

ZIM

The article discusses unusual options activity for several industrial stocks, highlighting potential trading opportunities. It provides details on call and put options for companies like GE, LYFT, ZIM, HWM, NVT, BA, BLDR, UAL, RUN, and VRT, with varying sentiments and expiration dates.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 5:35 pm

ANF

BABA

CPRI

PDD

SBUX

TSCO

TSLA

WYNN

The article highlights unusual options activity for 10 consumer discretionary stocks, indicating potential trading opportunities. Notable mentions include bullish sentiment for TSLA, SBUX, ANF, F, W, and CPRI, and bearish sentiment for BABA, PDD, WYNN, and TSCO.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 5:35 pm

AAPL

AMD

CRM

IBM

NTNX

NVDA

OKTA

PLTR

SMCI

The article highlights unusual options activity in the Information Technology sector, focusing on large transactions by 'whales' in stocks like NVDA, AMD, AAPL, SMCI, MU, NTNX, PLTR, CRM, OKTA, and IBM. These activities can indicate potential trading opportunities.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 5:35 pm

NAMS

Needham has initiated coverage on NewAmsterdam Pharma (NASDAQ:NAMS), highlighting its cholesterol drug obicetrapib as a potential blockbuster. The drug showed significant LDL-C reduction in trials, and Needham has set a Buy rating with a $36 price target. Obicetrapib could generate over $2 billion in sales, targeting 30 million patients.

Portfolio Pulse from Vandana Singh

August 28, 2024 | 5:33 pm

Unusual options activity for Goldman Sachs (NYSE:GS) has been observed, with a significant number of bullish positions taken by unknown investors. This suggests potential positive developments for GS. The options activity includes 16 notable trades, with a mix of puts and calls, indicating a price target range of $200 to $520. Analysts have mixed views, with target prices ranging from $500 to $561.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 5:31 pm

JNJ

Johnson & Johnson (JNJ) has seen a surge in options activity, with a notable bearish sentiment among big-money investors. The options trades include both puts and calls, with a significant portion being bearish. Analysts have adjusted their ratings and price targets, reflecting concerns about the stock's future performance.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 5:31 pm

Home Depot (NYSE:HD) has significantly outperformed the market over the past 20 years, with an annualized return of 12.14%. A $1000 investment in HD 20 years ago would be worth $9,933.56 today, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 5:30 pm